UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
(Mark One)
☑ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2018
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 000-23999
Manhattan Associates, Inc.
(Exact name of registrant as specified in its charter)
Georgia |
|
|
|
(State or other jurisdiction of incorporation or organization+ ) |
|
|
58-2373424 |
|
|
(I.R.S. Employer Identification No.) |
|
2300 Windy Ridge Parkway, Tenth Floor |
|
|
|
Atlanta, Georgia |
|
|
30339 |
( Address of principal executive offices ) |
|
|
( Zip Code ) |
Registrant’s telephone number, including area code: (770) 955-7070
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
Common Stock, $.01 par value per share |
|
The Nasdaq Stock Market LLC |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☑ No ☐
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☑
Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☑ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
Emerging Growth Company |
|
☐ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant as of June 30, 2018 was $3,091,365,142, which was calculated based upon a closing sales price of $47.01 per share of the Common Stock as reported by the Nasdaq Global Select Market on the same day. As of January 31, 2019, the Registrant had outstanding 65,017,683 shares of Common Stock.
DOCUMENTS INCORPORATED BY REFERENCE
The Registrant’s definitive Proxy Statement for the Annual Meeting of Shareholders to be held May 14, 2019 is incorporated by reference in Part III of this Form 10-K to the extent stated herein.
Manhattan Associates, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend its Annual Report on Form 10-K for the year ended December 31, 2018 (the “Original Form 10-K”), which was filed with the Securities and Exchange Commission on February 8, 2019. The purpose of this Amendment is to amend the table included in the section titled “Purchase of Equity Securities” in Part II, “Item 5. Market for Registrant’s Common Equity, Related Shareholder Matters, and Issuer Purchases of Equity Securities” (“Item 5”) of the Company’s Original Form 10-K. In the table in the Original Form 10-K, the Company inadvertently presented the amounts paid on share repurchases instead of the number of shares repurchased in the column heading “Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs.” This Amendment amends such disclosure to present the number of shares repurchased.
In addition, this Amendment amends Item 15 of Part IV of the Original Form 10-K to include new certifications by the Company’s principal executive officer (Exhibit 31.1) and principal financial officer (Exhibit 31.2) under Section 302 of the Sarbanes-Oxley Act of 2002 as required by Rule 12b-15 under the Securities Exchange Act of 1934.
Except for the foregoing, this Amendment does not reflect events occurring after the filing of the Original Form 10-K, does not update disclosures contained in the Form 10-K and does not modify or amend the Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K.
PART II
Market for Registrant’s Common Equity, Related Shareholder Matters, and Issuer Purchases of Equity Securities |
Market for Common Stock
Our common stock is traded on the Nasdaq Global Select Market under the symbol “MANH.” The number of registered shareholders of record of our common stock as of January 30, 2019 was approximately 13. The number of record holders does not include persons who held our common stock in nominee or “street name” accounts through brokers.
We do not intend to declare or pay cash dividends in the foreseeable future. Our management anticipates that all earnings and other cash resources, if any, will be retained for investment in our business.
Equity Compensation Plan Information
In the following table, we provide information regarding our current equity compensation plans as of December 31, 2018:
Plan Category |
|
Number of securities to be issued upon exercise of outstanding rights |
|
Weighted-average exercise price of outstanding rights |
|
Number of securities remaining available for future issuance under equity compensation plans |
Equity compensation plans approved by security holders |
|
997,173 |
|
$0.00 |
|
9,844,416 |
Equity compensation plans not approved by security holders |
|
- |
|
- |
|
- |
Total |
|
997,173 |
|
$0.00 |
|
9,844,416 |
You may find additional information regarding our equity compensation plans in Note 2 of the Notes to our Consolidated Financial Statements.
Purchase of Equity Securities
In the following table, we provide information regarding our common stock repurchases under our publicly-announced share repurchase program for the quarter ended December 31, 2018. All repurchases related to the share repurchase program were made on the open market.
Period |
|
Total Number of Shares Purchased |
|
Average Price Paid per Share |
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs |
October 1 - October 31, 2018 |
|
66,024 |
|
$45.39 |
|
66,024 |
|
$47,002,916 |
November 1 - November 30, 2018 |
|
321,459 |
|
48.31 |
|
321,459 |
|
31,473,743 |
December 1 - December 31, 2018 |
|
131,065 |
|
47.53 |
|
131,065 |
|
25,244,020 |
Total |
|
518,548 |
|
|
|
518,548 |
|
|
In 2018, we repurchased a total of 3,147,466 shares at an average price per share of $45.52 under our publicly-announced share repurchase program. In January 2019, our Board of Directors authorized us to repurchase up to an aggregate of $50 million of our common stock.
(a) 1. |
Financial Statements. |
The response to this item is submitted as a separate section of the Original Form 10-K. See Item 8 of the Original Form 10-K.
2. |
Financial Statement Schedule. |
The financial statement schedule is filed as a part of the Original Form 10-K.
3. Exhibits.
See (b) below.
(b) |
The exhibits listed below under “Exhibit Index” are filed with or incorporated by reference herein. Where such filing is made by incorporation by reference to a previously filed registration statement or report, such registration statement or report is identified in parentheses. |
(c) |
See Item 15(a)(2). |
The following exhibits are filed or incorporated by reference herein.
Exhibit |
|
Description |
||
|
|
|||
3.1 |
|
|||
|
|
|||
3.2 |
|
|||
|
|
|||
4.1 |
|
|||
|
|
|||
4.2 |
|
|||
|
|
|||
10.1(a) |
|
|||
|
|
|||
(b) |
|
|||
|
|
|||
(c) |
|
|||
|
|
|||
(d) |
|
|||
|
|
|||
10.2(a) |
|
|||
|
|
|||
(b) |
|
|||
|
|
|||
(c) |
|
|||
|
|
|||
(d) |
|
|||
|
|
|||
(e) |
|
|||
|
|
|||
(f) |
|
|||
|
|
|||
(g) |
|
|||
|
|
Exhibit |
|
Description |
||
|
|
|||
|
||||
|
|
|||
10.3 |
|
|||
|
|
|||
10.4 |
|
|||
|
|
|
||
10.5 |
|
|||
|
|
|
||
10.6* |
|
|||
|
|
|
||
10.7(a)* |
|
|||
|
|
|
||
(b)* |
|
|||
|
|
|
||
(c)* |
|
|||
|
|
|
||
(d)* |
|
|||
|
|
|
||
(e)* |
|
|||
|
|
|
||
(f)* |
|
|||
|
|
|
||
(g)* |
|
|||
|
|
|
||
(h)* |
|
|||
|
|
|
||
10.8* |
|
|||
|
|
|
||
10.9(a)* |
|
|||
|
|
|
||
(b)* |
|
|||
|
|
|
||
10.10* |
|
Exhibit |
|
Description |
||
|
|
|||
|
|
|||
10.11* |
|
|||
|
|
|
||
10.12(a)* |
|
|||
|
|
|
||
(b)* |
|
|||
|
|
|
||
10.13* |
|
|||
|
|
|
||
10.14 * |
|
|||
|
|
|
||
10.15 |
|
|||
|
|
|
||
10.16 |
|
|||
|
|
|
||
10.17(a)* |
|
|||
|
|
|
||
(b)* |
|
|||
|
|
|
||
(c)* |
|
|||
10.18* |
|
|||
|
|
|
||
10.19* |
|
|||
|
|
|
||
10.20* |
|
|||
|
|
|
||
10.21* |
|
|||
|
|
|
||
10.22* |
|
|||
|
|
|
||
10.23* |
|
|||
|
|
|
||
10.24* |
|
Exhibit |
|
Description |
||
|
|
|||
|
|
|
||
10.25* |
|
|||
|
|
|
||
10.26* |
|
|||
|
|
|
||
10.27* |
|
|||
|
|
|
||
10.28 |
|
|||
|
|
|
||
10.29* |
|
|||
|
|
|
||
10.30* |
|
|||
|
|
|
||
10.31* |
|
|||
|
|
|
||
10.32* |
|
|||
|
|
|
||
10.33* |
|
|||
|
|
|
||
|
|
|
||
21.1 |
|
|||
|
|
|
||
23.1 |
|
|||
|
|
|
||
31.1 + |
|
|||
|
|
|
||
31.2 + |
|
|||
|
|
|
||
32** |
|
|||
|
|
|
||
101.INS |
|
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (Incorporated by reference to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019). |
||
|
|
|
||
101.SCH |
|
XBRL Taxonomy Extension Schema Document (Incorporated by reference to Exhibit 101.SCH to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019) |
||
|
|
|
||
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document (Incorporated by reference to Exhibit 101.CAL to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019) |
||
|
|
|
||
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document (Incorporated by reference to Exhibit 101.DEF to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019) |
||
|
|
|
||
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document (Incorporated by reference to Exhibit 101.LAB to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019) |
||
|
|
|
Exhibit |
|
Description |
||
|
|
|||
|
XBRL Taxonomy Extension Presentation Linkbase Document (Incorporated by reference to Exhibit 101.PRE to the Company’s Annual Report for the period ended December 31, 2018 (File No. 000-23999), filed on February 8, 2019) |
* |
Management contract or compensatory plan or agreement. |
** |
Previously furnished pursuant to the Original Form 10-K. |
+ |
Filed herewith. |
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MANHATTAN ASSOCIATES, INC. |
||
|
|
|
By: |
|
/s/ Eddie Capel |
|
|
Eddie Capel |
|
|
President, Chief Executive Officer, and Director |
Date: March 15, 2019